Lijun Ma1, Shannon Fogh2, Steve E Braunstein2, Kurtis Auguste3, Philip V Theodosopoulos3, Michael W McDermott3, Penny K Sneed2. 1. Department of Radiation Oncology, University of California San Francisco (UCSF), San Francisco, CA, USA. lijun.ma@ucsf.edu. 2. Department of Radiation Oncology, University of California San Francisco (UCSF), San Francisco, CA, USA. 3. Department of Neurosurgery, University of California San Francisco (UCSF), San Francisco, CA, USA.
Abstract
OBJECTIVE: The objective of the present study was evaluation of the interrelationships between changes in the skull size and variations in the normal brain radiation dose during Gamma Knife surgery (GKS). METHODS: With use of systematic modeling within Leksell GammaPlan® (Elekta AB; Stockholm, Sweden) in each of 15 analyzed cases, the skull was "expanded" and "contracted" by variation of its measurement values from 0 to ±3 cm. The mean normal brain radiation dose was then computed for each variant of the adjusted skull size and compared with the original treatment plan. Variations in the maximum point dose delivered to selected critical anatomical structures were also investigated. RESULTS: With changes in the skull radius within ±3 cm, the maximum absolute deviation in the mean normal brain radiation dose was 0.8%. As the skull radius increased, the mean normal brain radiation dose also increased linearly (confidence level >99%) with a positive slope of 0.2% per centimeter of radius length change. The maximum point dose deviations in all evaluated critical anatomical structures did not exceed 0.5%, with an overall trend toward a dose increase in parallel with an increase in the skull radius. CONCLUSION: The small skull size of pediatric patients may be associated with dosimetric advantages in terms of normal brain sparing during GKS.
OBJECTIVE: The objective of the present study was evaluation of the interrelationships between changes in the skull size and variations in the normal brain radiation dose during Gamma Knife surgery (GKS). METHODS: With use of systematic modeling within Leksell GammaPlan® (Elekta AB; Stockholm, Sweden) in each of 15 analyzed cases, the skull was "expanded" and "contracted" by variation of its measurement values from 0 to ±3 cm. The mean normal brain radiation dose was then computed for each variant of the adjusted skull size and compared with the original treatment plan. Variations in the maximum point dose delivered to selected critical anatomical structures were also investigated. RESULTS: With changes in the skull radius within ±3 cm, the maximum absolute deviation in the mean normal brain radiation dose was 0.8%. As the skull radius increased, the mean normal brain radiation dose also increased linearly (confidence level >99%) with a positive slope of 0.2% per centimeter of radius length change. The maximum point dose deviations in all evaluated critical anatomical structures did not exceed 0.5%, with an overall trend toward a dose increase in parallel with an increase in the skull radius. CONCLUSION: The small skull size of pediatric patients may be associated with dosimetric advantages in terms of normal brain sparing during GKS.